Form 4: Humana CEO Rechtin Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Humana Inc. President & CEO James A. Rechtin reported transactions involving company stock, including acquisitions and holdings of options and restricted stock units.
Summary
- James A. Rechtin, President & CEO of Humana Inc., filed a Form 4 detailing changes in his beneficial ownership of company securities.
- The filing reports the acquisition of 35,633 shares of Humana Common stock on May 1, 2026, with no cost indicated.
- Following this transaction, Rechtin beneficially owns 63,938 shares of Humana Common stock.
- The filing also details holdings of derivative securities, including options and restricted stock units (RSUs).
- Rechtin holds options to purchase Humana Common stock with exercise prices of $458.185 and $367.21, with specific vesting schedules.
- Additionally, he holds 2,183 Restricted Stock Units (RSUs) and 49,687 RSUs under various stock incentive plans.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports routine insider transactions and holdings rather than new strategic information or financial performance.
Positives
- The CEO acquired a significant number of company shares (35,633), indicating continued investment in the company.
- The CEO holds a substantial number of derivative securities (options and RSUs), aligning his interests with long-term shareholder value.
- The transactions are made pursuant to a 10b5-1 plan, suggesting a pre-arranged trading strategy.
Risks
- The filing does not explicitly mention any risks.
- Indirect beneficial ownership through trusts could introduce complexities in understanding direct control.
Future Outlook
The filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts. The CEO's acquisition of shares and holdings in equity compensation align with typical executive compensation structures in the managed care and health insurance industry.
Related Party Transactions
- All shares held in two revocable trust(s) for the benefit of the reporting person and spouse, with reporting person and spouse being sole trustees.
Stakeholder Impact
- Shareholders: The CEO's acquisition of shares may be interpreted as a positive signal of confidence in the company's future prospects.
- Employees: The existence of stock incentive plans, as detailed in the filing, indicates a mechanism for employee and executive compensation tied to company performance.
- Management: The filing details the compensation structure for the President & CEO, which is a key aspect of corporate governance.
Next Steps
- Continued monitoring of insider transactions for any significant shifts in beneficial ownership.
- Vesting of stock options and RSUs according to the specified schedules.
Key Dates
| Date | Description |
|---|---|
| 05/01/2026 | Earliest transaction date reported and date of acquisition of 35,633 Humana Common shares. |
| 01/08/2024 | Grant date for certain stock options and restricted stock units. |
| 02/21/2024 | Grant date for certain stock options. |
| 01/08/2025 | First vesting date for a portion of stock options and RSUs granted on 01/08/2024. |
| 01/08/2026 | Second vesting date for a portion of stock options and RSUs granted on 01/08/2024. |
| 01/08/2027 | Third vesting date for a portion of stock options and RSUs granted on 01/08/2024. |
| 02/21/2025 | First vesting date for a portion of stock options granted on 02/21/2024. |
| 02/21/2026 | Second vesting date for a portion of stock options granted on 02/21/2024. |
| 02/21/2027 | Third vesting date for a portion of stock options granted on 02/21/2024. |
| 05/05/2026 | Date of signature on the Form 4 filing. |
Keywords
Humana Inc., HUM, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Beneficial Ownership, James A. Rechtin, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.